Screener
Ocular Therapeutix OCUL Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $666,699 | $737,060 |
| Accounts receivable, net | 24,347 | 30,650 |
| Inventory | 3,737 | 3,564 |
| Prepaid expenses and other current assets | 11,212 | 10,855 |
| Total current assets | 705,995 | 782,129 |
| Property and equipment, net | 18,425 | 19,676 |
| Restricted cash | 1,614 | 1,614 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's inventories?
- Ocular Therapeutix (OCUL) reported inventories of $3.74M in Q1 2026.
- How has Ocular Therapeutix's inventories changed year-over-year?
- Ocular Therapeutix's inventories increased by 14.3% year-over-year, from $3.27M to $3.74M.
- What is the long-term trend for Ocular Therapeutix's inventories?
- Over 5 years (2020 to 2025), Ocular Therapeutix's inventories has grown at a 24.3% compound annual growth rate (CAGR), from $1.2M to $3.56M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Ocular Therapeutix's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude